Hypertension and nephrology - 2013;17(05-06)

Hypertension and nephrology

DECEMBER 10, 2013

Hypertension and nephrology

DECEMBER 10, 2013

[Relationship of Adipokins with Diurnal Changes in Blood Pressure ]

KOLLER Ákos, KOVÁCS Imre, TARJÁN Jenő, HEGEDŰS Zoltán, VÉGH Tibor, HORVÁTH Judit, KERN András, KOVÁCS Nóra

Hypertension and nephrology

DECEMBER 10, 2013

[Early histopathological changes in new onset diabetes mellitus after renal transplantation]

BORDA Bernadett, LENGYEL Csaba, VÁRKONYI Tamás, SZABÓ Viktor, LÁZÁR György, KEMÉNY Éva, KUBIK András, IBRAHIM Munir Yasmin

[Introduction: New-onset diabetes after transplantation (NODAT) is one of the most common complications following kidney transplantation. The diagnosis of NODAT is often late or missed, therefore it impairs the implanted renal allograft. Patients and methods: Patients were randomized to receive cyclosporine A- or tacrolimusbased immunosuppression. One year after the transplantation, fasting and oral glucose tolerance tests were performed, and the patients were assigned to one of the following... tovább »

Hypertension and nephrology

DECEMBER 10, 2013

[Monitoring of effectiveness of ramipril-amlodipine fixed combination, a non-interventional trial (Ramona study). Subgroup analysis of patients with chronic kidney disease]

SIMONYI Gábor

[Hypertension and chronic kidney disease are independent cardiovascular risk factors. The 5th Cardiovascular Consensus Conference has recommended chronic kidney disease in high-risk category. In chronic kidney disease hypertension is observed in most cases. In patients with chronic kidney disease blood pressure targets are as 140/90 mmHg blood pressure below must be achieved without overt proteinuria. In chronic kidney disease combined antihypertensive therapy treatment should be initiated... tovább »

Hypertension and nephrology

DECEMBER 10, 2013

[Change in prescribing RAS inhibitors with respect of data of National Health Insurance Fund (NHIF)]

BARNA István, GYURCSÁNYI András

[The authors examined and analyzed monthly data of accounted prescription sales that were supported by the National Health Insurance Fund. They wished to determine how the use of angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARB) had changed. They separately evaluated how much this data was in accordance with the several, recently published articles about clinical trial results that compared inhibitors of the renin-angiotensin system (RAS... tovább »

Hypertension and nephrology

DECEMBER 10, 2013

Hypertension and nephrology

DECEMBER 10, 2013

[Managing medical quality and patient safety in an international dialysis network]

TÖRÖK Marietta, OROSZ Attila, CHARLOTTA Wollheim, JÖRGEN Hegbrant

[A dialysis provider’s core activities include providing dialysis care with excellent quality, ensuring a low variability across the clinic network and ensuring strong focus on patient safety. In this article, we summarize the pertinent components of the quality assurance and safety program of the Diaverum Renal Services Group. Concerning medical performance, the key components of a successful quality program are setting treatment targets; implementing evidence- based guidelines and clinical... tovább »

Hypertension and nephrology

DECEMBER 10, 2013

[Current diagnosis and treatment of membranous nephropathy]

KARDOS Magdolna, TISLÉR András, CSEPREKÁL Orsolya, STUDINGER Péter, FINTHA Attila

[Primary membranous nephropathy is a common glomerular disorder characterized by subepithelial immune deposits. The pathomechanism underlying these lesions has only recently been elucidated: M-type phospholipase A2receptor (PLA2R) protein emerged as being the leading autoantigen. Antibodies to PLA2R, typically of IgG4 subclass are expressed in 70-80% of patients with primary membranous nephropathy. The level of autoantibody to PLA2R was shown to correlate with disease severity and to change... tovább »